TGFβR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts.
作者信息
Duncan Daniel R, Chen Pei-Yu, Patterson Joseph T, Lee Yong-Ung, Hibino Narutoshi, Cleary Muriel, Naito Yuji, Yi Tai, Gilliland Thomas, Kurobe Hirotsugu, Church Spencer N, Shinoka Toshiharu, Fahmy Tarek M, Simons Michael, Breuer Christopher K
出版信息
J Am Coll Cardiol. 2015 Feb 10;65(5):512-4. doi: 10.1016/j.jacc.2014.08.057.
Abstract
摘要
相似文献
1
TGFβR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts.转化生长因子β受体1抑制可阻断组织工程血管移植物中狭窄的形成。
J Am Coll Cardiol. 2015 Feb 10;65(5):512-4. doi: 10.1016/j.jacc.2014.08.057.
2
Improvement of the breaking strength of wound by combined treatment with recombinant human G-CSF, recombinant human M-CSF, and a TGF-beta1 receptor kinase inhibitor in rat skin.重组人粒细胞集落刺激因子、重组人巨噬细胞集落刺激因子和转化生长因子-β1受体激酶抑制剂联合治疗对大鼠皮肤伤口断裂强度的改善作用。
Cancer Sci. 2008 May;99(5):1021-8. doi: 10.1111/j.1349-7006.2008.00761.x.
3
Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.转化生长因子-β信号通路的药理学抑制可减少急性恰加斯病的感染并预防心脏损伤。
Antimicrob Agents Chemother. 2009 Nov;53(11):4694-701. doi: 10.1128/AAC.00580-09. Epub 2009 Sep 8.
4
ALK5 inhibition maintains islet endothelial cell survival but does not enhance islet graft revascularisation or function.ALK5抑制可维持胰岛内皮细胞存活，但不会增强胰岛移植的血管再生或功能。
Horm Metab Res. 2015 Jan;47(1):78-83. doi: 10.1055/s-0034-1395567. Epub 2014 Nov 27.
5
6
SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism.SB-431542对滤过性手术后瘢痕形成的抑制作用及其潜在机制。
Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1698-706. doi: 10.1167/iovs.08-1675. Epub 2008 Dec 20.
7
Excessive Activation of TGFβ by Spinal Instability Causes Vertebral Endplate Sclerosis.脊柱不稳定导致的转化生长因子β过度激活会引起椎体终板硬化。
Sci Rep. 2016 Jun 3;6:27093. doi: 10.1038/srep27093.
8
Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.通过激活素受体样激酶-5抑制剂抑制转化生长因子-β可减轻肺纤维化。
Mol Med Rep. 2015 May;11(5):3808-13. doi: 10.3892/mmr.2015.3193. Epub 2015 Jan 13.
9
Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.凝血酶刺激血管平滑肌蛋白聚糖合成是通过蛋白酶激活受体-1 对转化生长因子β型 I 受体的转激活介导的。
J Biol Chem. 2010 Aug 27;285(35):26798-26805. doi: 10.1074/jbc.M109.092767. Epub 2010 Jun 22.
10
The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.Src 家族激酶抑制剂 PP2 和 PP1 通过直接和差异抑制 I 型和 II 型 TGF-β 受体来阻断 TGF-β1 介导的细胞反应。
Curr Cancer Drug Targets. 2011 May;11(4):524-35. doi: 10.2174/156800911795538075.
引用本文的文献
1
Hemodynamics and Wall Mechanics of Vascular Graft Failure.血管移植物失效的血液动力学和壁力学。
Arterioscler Thromb Vasc Biol. 2024 May;44(5):1065-1085. doi: 10.1161/ATVBAHA.123.318239. Epub 2024 Apr 4.
2
Tissue Engineering of Vascular Grafts: A Case Report From Bench to Bedside and Back.血管移植物的组织工程：从基础到临床再到基础的案例报告。
Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):399-409. doi: 10.1161/ATVBAHA.122.318236. Epub 2023 Jan 12.
3
Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth.组织工程血管移植物可转化为具有天然功能和生长能力的自体新血管。
Commun Med (Lond). 2022 Jan 10;2:3. doi: 10.1038/s43856-021-00063-7. eCollection 2022.
4
Imatinib attenuates neotissue formation during vascular remodeling in an arterial bioresorbable vascular graft.伊马替尼可减轻动脉生物可吸收血管移植物血管重塑过程中的新组织形成。
JVS Vasc Sci. 2020;1:57-67. doi: 10.1016/j.jvssci.2020.03.002. Epub 2020 Apr 11.
5
Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering.性和他莫昔芬混淆了心血管组织工程学中的小鼠实验研究。
Sci Rep. 2021 Apr 13;11(1):8037. doi: 10.1038/s41598-021-87006-3.
6
Spontaneous reversal of stenosis in tissue-engineered vascular grafts.组织工程血管移植物狭窄的自发逆转。
Sci Transl Med. 2020 Apr 1;12(537). doi: 10.1126/scitranslmed.aax6919.
7
A computational bio-chemo-mechanical model of in vivo tissue-engineered vascular graft development.体内组织工程血管移植物发育的计算生物化学 - 机械模型。
Integr Biol (Camb). 2020 Apr 14;12(3):47-63. doi: 10.1093/intbio/zyaa004.
8
Biomaterials and heart recovery: cardiac repair, regeneration and healing in the MCS era: a state of the "heart".生物材料与心脏恢复：MCS时代的心脏修复、再生与愈合：“心脏”现状
J Thorac Dis. 2018 Jul;10(Suppl 20):S2346-S2362. doi: 10.21037/jtd.2018.01.85.
9
Future Perspectives on the Role of Stem Cells and Extracellular Vesicles in Vascular Tissue Regeneration.干细胞和细胞外囊泡在血管组织再生中的作用的未来展望
Front Cardiovasc Med. 2018 Jul 3;5:86. doi: 10.3389/fcvm.2018.00086. eCollection 2018.
10
Bone marrow-derived mononuclear cell seeded bioresorbable vascular graft improves acute graft patency by inhibiting thrombus formation via platelet adhesion.骨髓源单核细胞种植的生物可吸收血管移植物通过抑制血小板黏附来减少血栓形成，从而改善急性移植物通畅率。
Int J Cardiol. 2018 Sep 1;266:61-66. doi: 10.1016/j.ijcard.2018.01.059.
本文引用的文献
1
TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling.TGF-β 信号在静脉移植物重塑过程中介导内皮细胞向间充质细胞转化（EndMT）。
Sci Transl Med. 2014 Mar 12;6(227):227ra34. doi: 10.1126/scitranslmed.3006927.
2
Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.心脏内皮-间充质转化（EndMT）的分子基础：EndMT 过程中 microRNAs 的差异表达。
Cell Signal. 2012 May;24(5):1031-6. doi: 10.1016/j.cellsig.2011.12.024. Epub 2012 Jan 5.
3
Late-term results of tissue-engineered vascular grafts in humans.人体组织工程血管移植物的晚期结果。
J Thorac Cardiovasc Surg. 2010 Feb;139(2):431-6, 436.e1-2. doi: 10.1016/j.jtcvs.2009.09.057.
4
Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.用脂肪酸共轭物对可生物降解聚酯进行表面改性以改善药物靶向性。
Biomaterials. 2005 Oct;26(28):5727-36. doi: 10.1016/j.biomaterials.2005.02.025. Epub 2005 Apr 18.
5
Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis.成熟血管内皮可通过内皮-间充质转分化产生平滑肌细胞：体外分析
Circ Res. 2002 Jun 14;90(11):1189-96. doi: 10.1161/01.res.0000021432.70309.28.
Zotero 插件